Table 3.
MS (n=150) | Controls (n=150) | P value | |
---|---|---|---|
CAP, dB/m | 335.2± 51.2 | 255.56 ± 60.8 | <0.0001 |
Steatosis stage | |||
S0 | 21 (14%) | 95 (63%) | <0.0001 |
S1 | 11 (7%) | 15 (10%) | 0.35 |
S2 | 11 (7%) | 3 (2%) | 0.03 |
S3 | 107 (71%) | 37 (25%) | <0.0001 |
LSM, kPa | 7.24 ± 3.25 | 6.52± 2.85 | 0.04 |
Fibrosis stage | |||
F0–1 | 87 (58%) | 118 (79%) | 0.0001 |
F2 | 28 (19%) | 11 (7%) | 0.002 |
F3 | 20 (13%) | 14 (9%) | 0.26 |
F4 | 15 (10%) | 8 (5%) | 0.10 |
Notes: Data are expressed as mean ± SD or number (percentage). Statistically significant values are shown in bold (P<0.05).
Abbreviations: CAP, controlled attenuation parameter; LSM, liver stiffness measurements; S, steatosis; F, fibrosis.